review article | Q7318358 |
scholarly article | Q13442814 |
P50 | author | Walter C. Willett | Q1133904 |
Graham Colditz | Q5592728 | ||
Susan E. Hankinson | Q76570836 | ||
P2860 | cites work | Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial | Q27860743 |
The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluation | Q28137833 | ||
Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer | Q28142158 | ||
Epidemiology of non-steroidal anti-inflammatory drugs and cancer | Q28196393 | ||
Risk of breast cancer associated with atypical hyperplasia of lobular and ductal types | Q28238049 | ||
Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis | Q28258638 | ||
Progesterone and estrogen receptors and mammary neoplasia in the Iowa Women's Health Study: how many kinds of breast cancer are there? | Q72010719 | ||
Incidence of female breast cancer among atomic bomb survivors, 1950-1985 | Q72421675 | ||
Dietary fat and sports activity as determinants for age at menarche | Q72892941 | ||
Genetics of breast cancer | Q73004105 | ||
Hereditary breast cancer | Q74333329 | ||
Caloric restriction and incidence of breast cancer | Q79755892 | ||
Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies | Q28280957 | ||
Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study | Q28283241 | ||
Proportion of breast cancer cases in the United States explained by well-established risk factors | Q28283778 | ||
The Effect of Raloxifene on Risk of Breast Cancer in Postmenopausal Women | Q29396434 | ||
Cumulative risk of breast cancer to age 70 years according to risk factor status: data from the Nurses' Health Study. | Q30620197 | ||
Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50302 women with breast cancer and 96973 women without the disease | Q30705774 | ||
Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease | Q30747351 | ||
In-utero and early life exposures in relation to risk of breast cancer | Q33806874 | ||
Is estradiol a genotoxic mutagenic carcinogen? | Q33851357 | ||
Optimal diets for prevention of coronary heart disease | Q34160163 | ||
The causes and prevention of cancer | Q34204331 | ||
Strategy of prevention: lessons from cardiovascular disease. | Q34782046 | ||
The role of prolactin in mammary carcinoma | Q35067253 | ||
Exposures in Childhood, Adolescence and Early Adulthood and Breast Cancer Risk: a Systematic Review of the Literature | Q35119030 | ||
Aromatase inhibitors for chemoprevention | Q35612327 | ||
Breast cancer mortality rates are levelling off or beginning to decline in many western countries: analysis of time trends, age-cohort and age-period models of breast cancer mortality in 20 countries | Q36134335 | ||
Pre-eclampsia in pregnancy and subsequent risk for breast cancer | Q36624347 | ||
Hypothesis: does breast cancer originate in utero? | Q37584827 | ||
Migration patterns and breast cancer risk in Asian-American women | Q39403629 | ||
A review of the epidemiology of human breast cancer | Q39858364 | ||
Endogenous hormones as a major factor in human cancer. | Q40333832 | ||
Reproductive factors and breast cancer | Q40862181 | ||
Recreational and occupational physical activities and risk of breast cancer | Q40871354 | ||
Breast cancer risk associated with proliferative breast disease and atypical hyperplasia | Q40877771 | ||
The aetiology and pathogenesis of human breast cancer | Q40933353 | ||
Increased cell division as a cause of human cancer | Q41202194 | ||
Folate: effects on carcinogenesis and the potential for cancer chemoprevention. | Q41255116 | ||
Toward a unified concept of mammary carcinogenesis | Q41435007 | ||
Serum hormones and the alcohol-breast cancer association in postmenopausal women | Q43595452 | ||
Breast Cancer Mortality Among Immigrants in Australia and Canada | Q43804050 | ||
Serum estradiol level and risk of breast cancer during treatment with raloxifene | Q43846631 | ||
Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies | Q43963634 | ||
First results from the International Breast Cancer Intervention Study (IBIS-I): a randomised prevention trial | Q44146948 | ||
Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk | Q44507925 | ||
Risk factors for breast cancer according to estrogen and progesterone receptor status | Q44753983 | ||
Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk | Q47229226 | ||
Dual effects of weight and weight gain on breast cancer risk | Q47300501 | ||
Mammographic features and breast cancer risk: effects with time, age, and menopause status | Q50594567 | ||
Is Estradiol a Genotoxic Mutagenic Carcinogen?1 | Q55982485 | ||
Leisure physical activity and age at menarche | Q56636030 | ||
A Prospective Study of Folate Intake and the Risk of Breast Cancer | Q57750801 | ||
Transient Increase in the Risk of Breast Cancer after Giving Birth | Q59265488 | ||
A unifying concept of the aetiology of breast cancer | Q68347227 | ||
Projecting individualized probabilities of developing breast cancer for white females who are being examined annually | Q69396132 | ||
Mortality from breast cancer after irradiation during fluoroscopic examinations in patients being treated for tuberculosis | Q69759118 | ||
Effects of alcohol consumption on plasma and urinary hormone concentrations in premenopausal women | Q70672621 | ||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | breast cancer | Q128581 |
breast neoplasm | Q23929670 | ||
P304 | page(s) | 213-8 | |
P577 | publication date | 2004-08-06 | |
P1433 | published in | Breast Cancer Research | Q2208481 |
P1476 | title | Towards an integrated model for breast cancer etiology: the lifelong interplay of genes, lifestyle, and hormones | |
P478 | volume | 6 |
Q36245897 | A Comprehensive Model of Colorectal Cancer by Risk Factor Status and Subsite Using Data From the Nurses' Health Study |
Q37440908 | A Prospective Study of the Relationship between Psychological Factors and Breast Cancer |
Q38030881 | A critical review why assessment of steroid hormone receptors in breast cancer should be quantitative. |
Q36250581 | A steroid metabolizing gene variant in a polyfactorial model improves risk prediction in a high incidence breast cancer population |
Q44067192 | Accumulation of oxidatively induced clustered DNA lesions in human tumor tissues. |
Q37341393 | Age at menopause and determinants of hysterectomy and menopause in a multi-ethnic community: the Hilo Women's Health Study |
Q35971618 | An immunohistochemical method to study breast cancer cell subpopulations and their growth regulation by hormones in three-dimensional cultures |
Q38818614 | Anti-cancer effect of metformin by suppressing signaling pathway of HER2 and HER3 in tamoxifen-resistant breast cancer cells |
Q36738668 | Anticancer effect of metformin on estrogen receptor-positive and tamoxifen-resistant breast cancer cell lines |
Q92331020 | Association between ESR1, ESR2, HER2, UGT1A4, and UGT2B7 polymorphisms and breast Cancer in Jordan: a case-control study |
Q37212023 | Association between MTHFR gene 1298A>C polymorphism and breast cancer susceptibility: a meta-analysis based on 38 case-control studies with 40,985 subjects |
Q33778852 | Association of 677 C>T (rs1801133) and 1298 A>C (rs1801131) polymorphisms in the MTHFR gene and breast cancer susceptibility: a meta-analysis based on 57 individual studies |
Q36507427 | Association of MTHFR Ala222Val (rs1801133) polymorphism and breast cancer susceptibility: An update meta-analysis based on 51 research studies |
Q54208544 | Association of promoter methylation of ERα and ERβ with sporadic breast cancer--a study from North India. |
Q45184299 | Association of striking life events with primary breast cancer in 265 Chinese women: a case-control study |
Q43893904 | Associations of polymorphisms of folate cycle enzymes and risk of breast cancer in a Brazilian population are age dependent |
Q58762425 | Beyond the Antioxidant Activity of Dietary Polyphenols in Cancer: the Modulation of Estrogen Receptors (ERs) Signaling |
Q37585095 | Biological determinants of endocrine resistance in breast cancer |
Q40447587 | Biomarkers of folate and vitamin B12 and breast cancer risk: report from the EPIC cohort. |
Q33708123 | Bisphosphonates for osteoporosis treatment are associated with reduced breast cancer risk |
Q33418922 | Breast cancer epidemiology according to recognized breast cancer risk factors in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial Cohort |
Q37861636 | Breast cancer prevention based on gene-environment interaction |
Q36924721 | Breast cancer risk following Hodgkin lymphoma radiotherapy in relation to menstrual and reproductive factors |
Q34559145 | Circulating sex hormones and mammographic breast density among postmenopausal women |
Q35659606 | Circulating sex steroids and breast cancer risk in premenopausal women |
Q43103606 | Control of mammary stem cell function by steroid hormone signalling. |
Q35571951 | Convergence and divergence of genetic and modular networks between diabetes and breast cancer |
Q26751985 | Diet and risk of breast cancer |
Q37848467 | Dietary modification for women after breast cancer treatment: a narrative review |
Q57142283 | Early breast cancer |
Q36919219 | Endogenous estrogen, testosterone and progesterone levels in relation to breast cancer risk |
Q26768636 | Environmental Chemical Assessment in Clinical Practice: Unveiling the Elephant in the Room |
Q27023016 | Estrogen, male dominance and esophageal adenocarcinoma: is there a link? |
Q36113238 | Exogenous estrogen protects mice from the consequences of obesity and alcohol |
Q38664941 | Experience of menopause in aboriginal women: a systematic review |
Q37052900 | Fertility drug use and mammographic breast density in a mammography screening cohort of premenopausal women |
Q38024316 | Folate and breast cancer: what about high-risk women? |
Q33882180 | GPER mediates estrogen-induced signaling and proliferation in human breast epithelial cells and normal and malignant breast |
Q35023058 | Generation of breast cancer stem cells by steroid hormones in irradiated human mammary cell lines |
Q35139194 | Genetic polymorphisms in estrogen-related genes and the risk of breast cancer among Han Chinese women |
Q87107296 | Genetic polymorphisms of ESR1, ESR2, CYP17A1, and CYP19A1 and the risk of breast cancer: a case control study from North India |
Q44660334 | Healthy lifestyle and risk of breast cancer among postmenopausal women in the European Prospective Investigation into Cancer and Nutrition cohort study |
Q41874946 | Healthy lifestyle and risk of breast cancer for indigenous and non-indigenous women in New Zealand: a case control study |
Q33555270 | Higher dietary folate intake reduces the breast cancer risk: a systematic review and meta-analysis |
Q43581949 | Hormone replacement therapy and some risk factors for breast cancer among Slovenian postmenopausal women |
Q51789346 | How estrogen fuels breast cancer. |
Q44010610 | Impact of recent parity on histopathological tumor features and breast cancer outcome in premenopausal Japanese women |
Q36631628 | Increased long-term recreational physical activity is associated with older age at natural menopause among heavy smokers: the California Teachers Study |
Q37077775 | Ingested Nitrate and Breast Cancer in the Spanish Multicase-Control Study on Cancer (MCC-Spain). |
Q38080039 | Lack of association between MHTFR Glu429Ala polymorphism and breast cancer susceptibility: a systematic review and meta-analysis of 29 research studies |
Q37367067 | Low-fat dietary pattern and risk of benign proliferative breast disease: a randomized, controlled dietary modification trial |
Q39855627 | Lynch syndrome: the influence of environmental factors on extracolonic cancer risk in hMLH1 c.C1528T mutation carriers and their mutation-negative sisters. |
Q90464089 | MTHFR, XRCC1 and OGG1 genetic polymorphisms in breast cancer: a case-control study in a population from North Sardinia |
Q90434304 | Mammographic Density and Circulating Sex Hormones: a Cross-Sectional Study in Postmenopausal Korean Women |
Q36508076 | Mapping of three genetic determinants of susceptibility to estrogen-induced mammary cancer within the Emca8 locus on rat chromosome 5. |
Q27025094 | Menopausal symptoms in young survivors of breast cancer: a growing problem without an ideal solution |
Q37598444 | Methylenetetrahydrofolate reductase polymorphisms and breast cancer risk in Chinese population: a meta-analysis of 22 case-control studies |
Q38036917 | MicroRNAs and drug resistance of breast cancer: basic evidence and clinical applications |
Q34576381 | Murine Mammary Epithelial Stem Cells: Discovery, Function, and Current Status |
Q49795581 | Oestrogen receptor beta isoform expression in sporadic colorectal cancer, familial adenomatous polyposis and progressive stages of colorectal cancer |
Q38081505 | Oxidative stress associated to dysfunctional adipose tissue: a potential link between obesity, type 2 diabetes mellitus and breast cancer |
Q33779337 | Patients with uterine leiomyoma exhibit a high incidence but low mortality rate for breast cancer. |
Q26861053 | Plant sterols as anticancer nutrients: evidence for their role in breast cancer |
Q37408124 | Policy and research recommendations emerging from the scientific evidence connecting environmental factors and breast cancer |
Q40541957 | Polycyclic aromatic hydrocarbons and postmenopausal breast cancer: An evaluation of effect measure modification by body mass index and weight change |
Q37392711 | Pregnancy characteristics and maternal breast cancer risk: a review of the epidemiologic literature |
Q35784828 | Progesterone regulation of stem and progenitor cells in normal and malignant breast |
Q37306276 | Proportion of invasive breast cancer attributable to risk factors modifiable after menopause |
Q89256873 | Protein Biomarkers for Breast Cancer Risk Are Specifically Correlated with Local Steroid Hormones in Nipple Aspirate Fluid |
Q90165902 | Reproductive characteristics are associated with gene-specific promoter methylation status in breast cancer |
Q39649230 | Reproductive factors related to childbearing and mammographic breast density. |
Q36051449 | Risk assessment: controversies and management of moderate- to high-risk individuals |
Q37052561 | Serum factors and clinical characteristics associated with serum E-screen activity |
Q51652478 | Short-term anastrozole therapy reduces Ki-67 and progesterone receptor expression in invasive breast cancer: a prospective, placebo-controlled, double-blind trial. |
Q57106904 | Signaling pathways and steroid receptors modulating estrogen receptor α function in breast cancer |
Q36477382 | Social inequalities in breast cancer mortality among French women: disappearing educational disparities from 1968 to 1996 |
Q89777911 | Socioeconomic inequalities in cancer incidence in Europe: a comprehensive review of population-based epidemiological studies |
Q26772042 | Soy Isoflavones and Breast Cancer Cell Lines: Molecular Mechanisms and Future Perspectives |
Q36680104 | Soy isoflavone extracts stimulate the growth of nude mouse xenografts bearing estrogen-dependent human breast cancer cells (MCF-7). |
Q37408121 | State of the evidence: the connection between breast cancer and the environment |
Q26799113 | Steroid hormones, steroid receptors, and breast cancer stem cells |
Q35558923 | Stress and breast cancer: from epidemiology to molecular biology |
Q35202536 | The After Breast Cancer Pooling Project: rationale, methodology, and breast cancer survivor characteristics |
Q35263089 | The Breakthrough Generations Study: design of a long-term UK cohort study to investigate breast cancer aetiology |
Q36481375 | The Immunohistochemical Expression of the Oestrogen Receptor (ER), HER-2/NEU and Cytokeratin 8/18 and 5/6 in Invasive Breast Carcinoma |
Q37033301 | The PI3K inhibitor taselisib overcomes letrozole resistance in a breast cancer model expressing aromatase |
Q35868802 | The biology of progesterone receptor in the normal mammary gland and in breast cancer |
Q35874242 | The contribution of risk factors to the higher incidence of invasive and in situ breast cancers in women with higher levels of education in the European prospective investigation into cancer and nutrition |
Q37903655 | The different roles of ER subtypes in cancer biology and therapy |
Q37690092 | Timing of pubertal stages and breast cancer risk: the Breakthrough Generations Study |
Q58803134 | Trends in incidence, mortality and survival in women with breast cancer from 1985 to 2012 in Granada, Spain: a population-based study |
Q38080937 | Triple negative breast cancer in a male-to-female transsexual |
Q36077410 | Understanding breast cancer risk -- where do we stand in 2005? |
Q43158472 | Unraveling genes, hormones, and breast cancer |
Q39373643 | Use of anastrozole in the chemoprevention and treatment of breast cancer: A literature review |
Q36267669 | Use of aspirin, other nonsteroidal anti-inflammatory drugs, and acetaminophen and postmenopausal breast cancer incidence |
Q34038195 | Vegetable protein and vegetable fat intakes in pre-adolescent and adolescent girls, and risk for benign breast disease in young women |
Q36126413 | Zinc and cancer: implications for LIV-1 in breast cancer |
Search more.